Barclays PLC — M&A Activity 2021

Jun 16, 2021

National Storage Mechanism | Additional information

Form 8.3 - Willis Towers Watson plc

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

	Name of person dealing (Note 1)	Barclays PLC.
	Company dealt in	WILLIS TOWERS WATSON PLC
	Class of relevant security to which the	ORD
	dealings being disclosed relate (Note 2)
	Date of dealing	14 June 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:		ORD
		Long		Short
		Number	(%)	Number	(%)
(1)	Relevant securities
		1,893,218	1.47%	235,448	0.18%
(2)	Derivatives (other than options):
		72,359	0.06%	94,581	0.07%
(3)	Options and agreements to
	purchase/sell:	6,100	0.00%	6,100	0.00%
	TOTAL:
		1,971,677	1.53%	336,129	0.26%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long			Short
	Number		(%)	Number		(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit
Purchase	2	255.6100 USD
Purchase	2	256.3600 USD
Purchase	4	257.1812 USD
Purchase	8	255.8200 USD
Purchase	16	255.6212 USD
Purchase	18	257.4900 USD
Purchase	21	255.0219 USD
Purchase	23	255.9060 USD
Purchase	36	255.3411 USD
Purchase	77	255.6700 USD
Purchase	100	255.7000 USD
Purchase	100	256.1100 USD
Purchase	100	255.7600 USD
Purchase	100	255.6500 USD
Purchase	155	255.6566 USD
Purchase	170	256.1600 USD
Purchase	172	255.9424 USD
Purchase	181	255.8065 USD
Purchase	200	255.3975 USD
Purchase	206	256.0987 USD
Purchase	218	256.0445 USD
Purchase	300	255.4966 USD
Purchase	334	256.1218 USD
Purchase	400	255.8274 USD
Purchase	499	255.3304 USD
Purchase	587	255.1279 USD
Purchase	798	256.0968 USD
Purchase	929	255.2813 USD
Purchase	1,017	255.3067 USD
Purchase	1,185	255.1338 USD
Purchase	1,436	255.4707 USD
Purchase	1,954	256.3949 USD
Purchase	2,075	255.5663 USD
Purchase	2,363	255.8104 USD
Purchase	2,535	255.0012 USD
Purchase	2,585	255.0015 USD
Purchase	3,034	255.8859 USD
Purchase	3,867	255.0240 USD
Purchase	5,309	256.2285 USD
Purchase	6,617	255.3729 USD
Purchase	10,989	255.7332 USD
Purchase	16,171	256.1200 USD
Sale	1	256.7400 USD
Sale	18	257.4900 USD
Sale	100	256.5400 USD
Sale	100	256.4400 USD
Sale	108	255.8200 USD
Sale	128	255.4071 USD
Sale	170	256.1600 USD
Sale	200	255.9000 USD
Sale	200	255.5100 USD
Sale	200	255.3975 USD
Sale	300	255.6533 USD
Sale	330	255.8509 USD
Sale	355	255.3021 USD
Sale	608	255.8381 USD
Sale	1,158	255.9200 USD
Sale	1,379	255.4701 USD
Sale	1,671	255.3462 USD
Sale	1,876	255.8649 USD
Sale	1,953	255.6060 USD
Sale	1,954	256.3949 USD
Sale	2,685	256.1215 USD
Sale	3,439	256.1214 USD
Sale	4,500	256.1358 USD
Sale	4,555	255.1346 USD
Sale	4,752	256.2500 USD
Sale	6,413	255.8529 USD
Sale	6,841	255.4927 USD
Sale	7,772	256.1200 USD
Sale	10,193	255.0255 USD

(b) Derivatives transactions (other than options transactions)

Product name, e.g. CFD	Nature of transaction (Note 6)	Number of relevant securities (Note 7)	Price per unit (Note 5)

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)

(ii) Exercising

Product name, e.g. call option	Number of securities	Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)	Details	Price per unit (if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name	Written or	Number of	Exercise	Type	Expiry
	purchased	relevant securities	price		date
		to which the option
		or derivative
		relates
Put Options	Purchased	-100	220.0000	American	Jul 16, 2021
Call Options	Purchased	100	240.0000	American	Jul 16, 2021
Call Options	Purchased	6,000	220.0000	American	Jul 16, 2021
Put Options	Purchased	-6,000	200.0000	American	Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210616005461/en/

BARCLAYS PLC